Role of differentiation induction in tumor suppression.
Marks
P A
PA
Memorial Sloan-Kettering Cancer Center, Graduate School of Medical Sciences, Cornell University, New York, New York.
Rifkind
R A
RA
D000081:Acetamides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D004341:Drug Evaluation; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D005786:Gene Expression Regulation / Q000187:drug effects; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D004915:Leukemia, Erythroblastic, Acute / Q000235:genetics / Q000473:pathology; D051379:Mice; D009369:Neoplasms / Q000628:therapy; D011519:Proto-Oncogenes / Q000187:drug effects; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
D000081:Acetamides; D000970:Antineoplastic Agents; C014026:hexamethylene bisacetamide